PL2188306T3 - Fragmenty powstałe po cięciu immunoglobuliny jako wskaźniki choroby oraz kompozycje do ich wykrywania i wiązania - Google Patents
Fragmenty powstałe po cięciu immunoglobuliny jako wskaźniki choroby oraz kompozycje do ich wykrywania i wiązaniaInfo
- Publication number
- PL2188306T3 PL2188306T3 PL08782610T PL08782610T PL2188306T3 PL 2188306 T3 PL2188306 T3 PL 2188306T3 PL 08782610 T PL08782610 T PL 08782610T PL 08782610 T PL08782610 T PL 08782610T PL 2188306 T3 PL2188306 T3 PL 2188306T3
- Authority
- PL
- Poland
- Prior art keywords
- binding
- compositions
- detecting
- cleavage fragments
- disease indicators
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 238000003776 cleavage reaction Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000007017 scission Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95516207P | 2007-08-10 | 2007-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2188306T3 true PL2188306T3 (pl) | 2017-01-31 |
Family
ID=40351057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08782610T PL2188306T3 (pl) | 2007-08-10 | 2008-08-04 | Fragmenty powstałe po cięciu immunoglobuliny jako wskaźniki choroby oraz kompozycje do ich wykrywania i wiązania |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20090155280A1 (pl) |
| EP (1) | EP2188306B1 (pl) |
| JP (2) | JP5530356B2 (pl) |
| KR (2) | KR20150059813A (pl) |
| CN (2) | CN101889021B (pl) |
| AU (1) | AU2008287128B2 (pl) |
| BR (1) | BRPI0814355A2 (pl) |
| CA (1) | CA2696011A1 (pl) |
| DK (1) | DK2188306T3 (pl) |
| EA (1) | EA025220B1 (pl) |
| ES (1) | ES2593791T3 (pl) |
| HU (1) | HUE029649T2 (pl) |
| IL (1) | IL203544A (pl) |
| MX (1) | MX2010001616A (pl) |
| NZ (1) | NZ582916A (pl) |
| PL (1) | PL2188306T3 (pl) |
| PT (1) | PT2188306T (pl) |
| SG (1) | SG183701A1 (pl) |
| WO (1) | WO2009023457A1 (pl) |
| ZA (1) | ZA201001689B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501907B2 (en) * | 2007-08-10 | 2013-08-06 | Janssen Biotech, Inc. | Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| CA3031851C (en) | 2009-10-23 | 2020-07-07 | Amgen British Columbia | Anti-gcc antibody molecules and related compositions and methods |
| BR112012010252A2 (pt) | 2009-10-29 | 2016-12-06 | Janssen Biotech Inc | variantes de glicosilação de anticorpo |
| US8041225B2 (en) * | 2009-12-21 | 2011-10-18 | General Electric Company | Contactless infrared data transmission for wind turbines |
| US20120269834A1 (en) * | 2010-11-19 | 2012-10-25 | Robert Jordan | Immunoglobulin cleavage fragment vaccine compositions |
| KR101820558B1 (ko) | 2010-12-23 | 2018-02-28 | 유리타 아. 게. | 넓은 영역에 나노 구조체를 생산하기 위한 시스템 및 방법 |
| JP6012624B2 (ja) | 2010-12-23 | 2016-10-25 | ヤンセン バイオテツク，インコーポレーテツド | 活性プロテアーゼ耐性抗体Ｆｃ突然変異体 |
| KR102046435B1 (ko) * | 2012-04-27 | 2019-11-19 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 항-gcc 항체 분자 및 gcc-표적화 치료법에 대한 감수성을 평가하기 위한 그 용도 |
| US10654933B2 (en) * | 2013-12-27 | 2020-05-19 | Chugai Seiyaku Kabushiki Kaisha | Method for purifying antibody having low isoelectric point |
| ES2861600T3 (es) | 2014-04-04 | 2021-10-06 | Mayo Found Medical Education & Res | Isotipaje de inmunoglobulinas usando masa molecular precisa |
| US11209439B2 (en) | 2015-09-24 | 2021-12-28 | Mayo Foundation For Medical Education And Research | Identification of immunoglobulin free light chains by mass spectrometry |
| WO2018049001A1 (en) | 2016-09-07 | 2018-03-15 | Mayo Foundation For Medical Education And Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
| WO2019055632A1 (en) | 2017-09-13 | 2019-03-21 | Mayo Foundation For Medical Education And Research | IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J |
| US11946937B2 (en) | 2017-09-13 | 2024-04-02 | Mayo Foundation For Medical Education And Research | Identification and monitoring of apoptosis inhibitor of macrophage |
| TW201925233A (zh) | 2017-12-07 | 2019-07-01 | 日商中外製藥股份有限公司 | 抗體、用於在樣品中偵測或捕捉多肽的組成物以及在樣品中偵測或捕捉多肽的方法 |
| US20210325380A1 (en) * | 2020-04-20 | 2021-10-21 | EnLiSense, LLC | Disease diagnostics using a multi-configurable sensing array |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2162863T3 (es) * | 1993-04-29 | 2002-01-16 | Unilever Nv | Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae. |
| AUPM322393A0 (en) * | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| US7129331B2 (en) * | 2000-05-31 | 2006-10-31 | Pestka Biomedical Laboratories, Inc. | Phosphorylated polypeptides and uses related thereto |
| GB0130228D0 (en) * | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
-
2008
- 2008-08-04 PL PL08782610T patent/PL2188306T3/pl unknown
- 2008-08-04 ES ES08782610.3T patent/ES2593791T3/es active Active
- 2008-08-04 EP EP08782610.3A patent/EP2188306B1/en not_active Not-in-force
- 2008-08-04 HU HUE08782610A patent/HUE029649T2/en unknown
- 2008-08-04 NZ NZ582916A patent/NZ582916A/xx not_active IP Right Cessation
- 2008-08-04 MX MX2010001616A patent/MX2010001616A/es active IP Right Grant
- 2008-08-04 JP JP2010520241A patent/JP5530356B2/ja not_active Expired - Fee Related
- 2008-08-04 PT PT87826103T patent/PT2188306T/pt unknown
- 2008-08-04 AU AU2008287128A patent/AU2008287128B2/en not_active Ceased
- 2008-08-04 BR BRPI0814355-2A2A patent/BRPI0814355A2/pt not_active IP Right Cessation
- 2008-08-04 WO PCT/US2008/072083 patent/WO2009023457A1/en not_active Ceased
- 2008-08-04 CA CA2696011A patent/CA2696011A1/en not_active Abandoned
- 2008-08-04 KR KR1020157013122A patent/KR20150059813A/ko not_active Ceased
- 2008-08-04 US US12/185,333 patent/US20090155280A1/en not_active Abandoned
- 2008-08-04 KR KR1020107005265A patent/KR101588276B1/ko not_active Expired - Fee Related
- 2008-08-04 CN CN200880102840.1A patent/CN101889021B/zh not_active Expired - Fee Related
- 2008-08-04 SG SG2012058665A patent/SG183701A1/en unknown
- 2008-08-04 EA EA201070236A patent/EA025220B1/ru not_active IP Right Cessation
- 2008-08-04 DK DK08782610.3T patent/DK2188306T3/en active
- 2008-08-04 CN CN201310054803.0A patent/CN103497254B/zh not_active Expired - Fee Related
-
2010
- 2010-01-27 IL IL203544A patent/IL203544A/en not_active IP Right Cessation
- 2010-03-09 ZA ZA2010/01689A patent/ZA201001689B/en unknown
-
2013
- 2013-10-30 JP JP2013225205A patent/JP2014058535A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008287128A1 (en) | 2009-02-19 |
| AU2008287128B2 (en) | 2013-07-18 |
| EP2188306B1 (en) | 2016-06-29 |
| CN103497254A (zh) | 2014-01-08 |
| JP5530356B2 (ja) | 2014-06-25 |
| CN103497254B (zh) | 2016-12-28 |
| CA2696011A1 (en) | 2009-02-19 |
| EP2188306A4 (en) | 2011-03-02 |
| BRPI0814355A2 (pt) | 2015-01-27 |
| HUE029649T2 (en) | 2017-02-28 |
| US20090155280A1 (en) | 2009-06-18 |
| CN101889021B (zh) | 2016-06-08 |
| ES2593791T3 (es) | 2016-12-13 |
| EP2188306A1 (en) | 2010-05-26 |
| WO2009023457A1 (en) | 2009-02-19 |
| NZ582916A (en) | 2012-08-31 |
| KR101588276B1 (ko) | 2016-01-26 |
| IL203544A (en) | 2015-07-30 |
| KR20100059850A (ko) | 2010-06-04 |
| ZA201001689B (en) | 2011-06-29 |
| CN101889021A (zh) | 2010-11-17 |
| JP2010536037A (ja) | 2010-11-25 |
| MX2010001616A (es) | 2010-03-15 |
| KR20150059813A (ko) | 2015-06-02 |
| SG183701A1 (en) | 2012-09-27 |
| DK2188306T3 (en) | 2016-08-22 |
| PT2188306T (pt) | 2016-09-13 |
| EA025220B1 (ru) | 2016-12-30 |
| JP2014058535A (ja) | 2014-04-03 |
| EA201070236A1 (ru) | 2010-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201001689B (en) | Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such | |
| EP2247310A4 (en) | COMPOSITIONS AND METHODS FOR CRYSTALLIZING ANTIBODY FRAGMENTS | |
| GB2464430B (en) | Emulsified composition | |
| PL2061346T3 (pl) | Kompozycja spożywcza zmniejszająca uczulenie na alergen | |
| ZA201000983B (en) | Methods and compositions for diagnosing disease | |
| ZA200807960B (en) | Catalyst composition | |
| GB0713232D0 (en) | Staple remover | |
| GB0719065D0 (en) | coalescing materials | |
| EP2068819A4 (en) | Dendrimer COMPOSITIONS | |
| ZA200903656B (en) | Novel composition | |
| EP2278984A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY | |
| EP1997013A4 (en) | IDENTIFICATION OF MODIFICATIONS TO CONTENTS OF MEDIA DEVICES | |
| IL208188A0 (en) | Compositions comprising antibodies or antibody fragments | |
| EP2034019A4 (en) | COMPOSITION FOR THE NUCLEENIC ACID INTRODUCTION | |
| PL386709A1 (pl) | Kompozycja oczyszczająca | |
| GB2450822B (en) | Sample preparation | |
| HK1142915A (en) | Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such | |
| GB0621329D0 (en) | Novel composition | |
| GB0622341D0 (en) | Novel compounds and methods for their preparation | |
| GB0621279D0 (en) | Binding site | |
| HK1152948A (en) | Compositions comprising antibodies to lingo or fragments thereof | |
| AU3501P (en) | Sentinel 3R Triticum aestivum | |
| HK1150427A (en) | Compositions and methods for crystallizing antibody fragments | |
| GB0723044D0 (en) | Lyophillised antigen composition | |
| GB0723900D0 (en) | Lyophillised antigen composition |